disease 1,504 words KG: ent-dise-9b2d6832
Contents

Nasu-Hakola Disease (PLOSL)

Disease Info
Cognitive declineProgressive presenile dementia resembling Alzheimer's Disease
Behavioral changesFrontal lobe syndrome with personality alterations, loss of social inhibitions, aggressive behavior
Mood disturbancesEuphoria, apathy, depression
Speech disordersDysarthria, eventual mutism
Motor symptomsUpper motor neuron signs including spasticity, myoclonus, gait disturbance
SeizuresGeneralized tonic-clonic seizures
Agnosia and apraxiaLoss of sensory and motor planning abilities
Memory impairmentProgressive forgetfulness and cognitive deficits
DatabasesOMIMOrphanetClinicalTrialsPubMed

No AI portrait yet

Knowledge Graph

Related Hypotheses (6)

TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.69
TREM2-mediated microglial tau clearance enhancement
Score: 0.62
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.76
APOE-TREM2 Interaction Modulation
Score: 0.74
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.58
TREM2-Dependent Microglial Senescence Transition
Score: 0.54

Related Analyses (16)

Synaptic pruning by microglia in early AD
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed
TREM2 agonism vs antagonism in DAM microglia
neurodegeneration · completed

Related Experiments (3)

Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.45
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.45
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.45

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)